lometrexol

DRUG2 trials

Sponsors

Jonsson Comprehensive Cancer Center, Tularik

Conditions

Drug/Agent Toxicity by Tissue/OrganLung CancerUnspecified Adult Solid Tumor, Protocol Specific

Phase 1

Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Jonsson Comprehensive Cancer CenterDrug/Agent Toxicity by Tissue/Organ, Unspecified Adult Solid Tumor, Protocol Specific

Start: 2001-09-30Updated: 2013-09-17

Phase 2

Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

TularikLung Cancer

Start: 2002-02-28Updated: 2014-01-06